Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced that it has signed a master service agreement with Omnicare Clinical Research, a leading global CRO, for distribution of clinical trial materials in Europe and Asia Pacific.

Under the terms of the agreement, Omnicare Clinical Research's clinical supplies division will provide Patheon's customers with various clinical supply services that include monitoring, distribution and return accountability. The agreement now enables Patheon to provide a broader clinical materials service to its clients.

Dr Colin Minchom, Patheon's vice president for Pharmaceutical Development Services, North America, stated, "We are excited to expand our expertise and development and clinical packaging capabilities with assistance from Omnicare Clinical Research. By leveraging Omnicare Clinical Research's strengths, we're able to provide Patheon's clients with a greater variety of manufacturing and packaging options, including distribution locations for clinical trial materials in Europe and Asia Pacific."